Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epigenetic silencing of HTLV-1 expression by the HBZ RNA through interference with the basal transcription machinery.

Literature DB >> 33170933

Epigenetic silencing of HTLV-1 expression by the HBZ RNA through interference with the basal transcription machinery.

Hélène Gazon^1,2, Pradeep Singh Chauhan^1,2, Florent Porquet^1,2, Gabriela Brunsting Hoffmann^1,2, Roberto Accolla³, Luc Willems^1,2.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2020 PMID： 33170933 PMCID： PMC7656924 DOI： 10.1182/bloodadvances.2020001675

Source DB: PubMed Journal: Blood Adv ISSN： 2473-9529

× No keyword cloud information.

22 in total

Review 1. Reducing the global burden of HTLV-1 infection: An agenda for research and action.

Authors: Luc Willems; Hideki Hasegawa; Roberto Accolla; Charles Bangham; Ali Bazarbachi; Umberto Bertazzoni; Anna Barbara de Freitas Carneiro-Proietti; Hua Cheng; Luigi Chieco-Bianchi; Vincenzo Ciminale; Jordana Coelho-Dos-Reis; José Esparza; Robert C Gallo; Antoine Gessain; Eduardo Gotuzzo; William Hall; Joseph Harford; Olivier Hermine; Steven Jacobson; Beatrice Macchi; Calum Macpherson; Renaud Mahieux; Masao Matsuoka; Edward Murphy; Jean-Marie Peloponese; Viviana Simon; Yutaka Tagaya; Graham P Taylor; Toshiki Watanabe; Yoshihisa Yamano
Journal: Antiviral Res Date: 2016-11-11 Impact factor: 5.970

2. Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs.

Authors: Francesca Rende; Ilaria Cavallari; Alberto Corradin; Micol Silic-Benussi; Frederic Toulza; Gianna M Toffolo; Yuetsu Tanaka; Steven Jacobson; Graham P Taylor; Donna M D'Agostino; Charles R M Bangham; Vincenzo Ciminale
Journal: Blood Date: 2011-03-11 Impact factor: 22.113

3. HLA class I binding of HBZ determines outcome in HTLV-1 infection.

Authors: Aidan Macnamara; Aileen Rowan; Silva Hilburn; Ulrich Kadolsky; Hiroshi Fujiwara; Koichiro Suemori; Masaki Yasukawa; Graham Taylor; Charles R M Bangham; Becca Asquith
Journal: PLoS Pathog Date: 2010-09-23 Impact factor: 6.823

4. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms.

Authors: Yuko Taniguchi; Kisato Nosaka; Jun-ichirou Yasunaga; Michiyuki Maeda; Nancy Mueller; Akihiko Okayama; Masao Matsuoka
Journal: Retrovirology Date: 2005-10-22 Impact factor: 4.602

5. Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL.

Authors: Goutham U Raval; Carlo Bidoia; Greta Forlani; Giovanna Tosi; Antoine Gessain; Roberto S Accolla
Journal: Retrovirology Date: 2015-07-04 Impact factor: 4.602

6. Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).

Authors: Marco Baratella; Greta Forlani; Goutham U Raval; Alessandra Tedeschi; Olivier Gout; Antoine Gessain; Giovanna Tosi; Roberto S Accolla
Journal: PLoS Negl Trop Dis Date: 2017-01-17

7. Single-cell heterogeneity and cell-cycle-related viral gene bursts in the human leukaemia virus HTLV-1.

Authors: Martin R Billman; David Rueda; Charles R M Bangham
Journal: Wellcome Open Res Date: 2017-09-22

8. HTLV-1 bZIP Factor RNA and Protein Impart Distinct Functions on T-cell Proliferation and Survival.

Authors: Yuichi Mitobe; Jun-ichirou Yasunaga; Rie Furuta; Masao Matsuoka
Journal: Cancer Res Date: 2015-09-17 Impact factor: 13.312

9. Human T-Lymphotropic Virus type 1 infection in an Indigenous Australian population: epidemiological insights from a hospital-based cohort study.

Authors: Lloyd Einsiedel; Richard J Woodman; Maria Flynn; Kim Wilson; Olivier Cassar; Antoine Gessain
Journal: BMC Public Health Date: 2016-08-15 Impact factor: 3.295

Epigenetic silencing of HTLV-1 expression by the HBZ RNA through interference with the basal transcription machinery.

Review 1. Reducing the global burden of HTLV-1 infection: An agenda for research and action.

2. Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs.

3. HLA class I binding of HBZ determines outcome in HTLV-1 infection.

4. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms.

5. Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL.

6. Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).

7. Single-cell heterogeneity and cell-cycle-related viral gene bursts in the human leukaemia virus HTLV-1.

8. HTLV-1 bZIP Factor RNA and Protein Impart Distinct Functions on T-cell Proliferation and Survival.

9. Human T-Lymphotropic Virus type 1 infection in an Indigenous Australian population: epidemiological insights from a hospital-based cohort study.

Review 10. Silencers of HTLV-1 and HTLV-2: the pX-encoded latency-maintenance factors.

Review 1. Functional and Pathogenic Roles of Retroviral Antisense Transcripts.

2. Transcriptional regulators of human oncoviruses: structural and functional implications for anticancer therapy.

Review 3. Current Perspectives in Human T-Cell Leukemia Virus Type 1 Infection and Its Associated Diseases.

Review 4. The Road to HTLV-1-Induced Leukemia by Following the Subcellular Localization of HTLV-1-Encoded HBZ Protein.